Skip to main content
. 2012 Sep 11;79(11):1130–1135. doi: 10.1212/WNL.0b013e3182698c64

Table 1.

Summary of studies examining DMD exposure during pregnancy and conception in MS

graphic file with name znl03512-0269-t01.jpg

Abbreviations: DMD = disease-modifying drug; GA = glatiramer acetate; IFN-β = interferon β LMP = last menstrual period; MS = multiple sclerosis.

a

Patients were compared with population estimates instead of individual subjects recruited as controls.

b

Studies with potential conflicts of interest due to direct funding support from the pharmaceutical manufacturer.

c

Studies with unknown/unclear conflicts of interest.

d

Studies with potential conflicts of interest due to employment of author by the pharmaceutical manufacturer.